News

Katena Products Announces the Acquisition of Sensor Medical Technology

22 January 2016

Denville, NJ - January 22, 2016 - Katena Products, a leading global provider of precision ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices announces the acquisition of Sensor Medical Technology ("SMT").

Based in Maple Valley, WA, SMT specializes in the development and manufacture of high quality single-use and reusable diagnostic and therapeutic lenses used by ophthalmologists and optometrists in the U.S. and globally.

"The acquisition of SMT is an important addition to Katena's product portfolio. SMT disposable and reusable lenses represent an improvement to current clinical practice, as it relates to consistently better optics, while eliminating the chance of disease transmission." said Bill Friedberg, CEO of Katena Products. "We enthusiastically welcome the SMT team to Katena and look forward to working together to grow the business."

Greg Heacock, Founder and CEO of SMT, said, "We are excited to see Katena and SMT come together, enabling SMT to accelerate growth through Katena's worldwide sales and marketing channels. This is the perfect marriage of high quality instruments and optics and the combination will provide doctors with a broad range of solutions for their patient procedures."

About Katena Products, Inc.

Katena Products, Inc. is a market-leader in specialty surgical and consumable ophthalmic products. It provides an extensive line of instruments, therapeutics, and devices to physician offices, hospitals, and surgical centers in over 110 countries through a U.S. sales force and extensive international distributor network. Katena is focused on expanding its offerings beyond its leading products in the core instruments and biologics market segments. For additional information, please visit www.katena.com

Katena Products, Inc. and its parent company Katena Holdings, are owned by Audax Group, a Boston-based firm. Audax Group is a leading investor in middle market companies, which currently manages over $9.0 billion of assets through its private equity, mezzanine debt, and private senior debt businesses.